Annex Advisory Services, LLC Exact Sciences Corp Transaction History

Annex Advisory Services, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	BUY	$62.68 - $95.05 $150,181 - $227,739	2,396 New	2,396 $224,000
Q2 2022 Jul 27, 2022	SELL	$35.61 - $76.23 $121,323 - $259,715	-3,407 Closed	0 $0
Q1 2022 Apr 13, 2022	SELL	$57.56 - $82.54 $2,072 - $2,971	-36 Reduced 1.05%	3,407 $238,000
Q4 2021 Jan 31, 2022	BUY	$72.5 - $100.68 $93,815 - $130,279	1,294 Added 60.21%	3,443 $268,000
Q3 2021 Oct 18, 2021	SELL	$90.24 - $124.05 $66,777 - $91,797	-740 Reduced 25.61%	2,149 $205,000
Q4 2020 Jan 28, 2021	BUY	$99.61 - $142.12 $19,922 - $28,424	200 Added 7.44%	2,889 $383,000
Q3 2020 Oct 23, 2020	SELL	$72.92 - $102.01 $4,229 - $5,916	-58 Reduced 2.11%	2,689 $274,000
Q2 2020 Jul 21, 2020	SELL	$55.75 - $92.75 $2.74 Million - $4.55 Million	-49,070 Reduced 94.7%	2,747 $239,000
Q4 2019 Feb 10, 2020	BUY	$77.66 - $99.74 $4.02 Million - $5.17 Million	51,817 New	51,817 $691,000
Q4 2018 Feb 12, 2019	SELL	$56.04 - $82.66 $168,120 - $247,980	-3,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$48.29 - $80.6 $144,870 - $241,799	3,000 New	3,000 $237,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Annex Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Annex Advisory Services, LLC with notifications on news.